Healthcare

SINGAPORE (Aug 20): Changes to government schemes on healthcare and housing were outlined by Prime Minister Lee Hsien Loong in his National Day Rally speech on Sunday night.

SINGAPORE (Aug 6): When K Leela, 68, was diagnosed with kidney failure about a decade ago, she panicked about the cost. The homemaker needs to have dialysis at least twice a week, for life. Her husband works as a hotel bellhop, and they have three childre

SINGAPORE (July 13): Acromec has secured a contract valued at $2.9 million for the outfitting of a private day-surgery centre.

SINGAPORE (July 11): UOB Kay Hian is starting Asian Healthcare Specialists (AHS) at “buy” with a target price of 33 cents as it views the stock as a proxy to increased medical spending from Singapore’s ageing population and rising participation in s

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Ge

SINGAPORE (May 24): Boustead Singapore announced that it is acquiring 100% of the shareholding of WhiteRock Incorporation (WRI), which comprises a group of 16 healthcare corporations operating in Singapore, China, Hong Kong, Malaysia and Thailand for $19

SINGAPORE (May 17): Hyphens Pharma International says its public offering of 3 million shares at 26 cents per share in conjunction with its Catalist listing was about 152 times subscribed.

SINGAPORE (May 2): HealthBaby Biotech (Hong Kong), a wholly-owned subsidiary of Cordlife Group, has launched a newborn metabolic screening service in Hong Kong.

SINGAPORE (May 2): RHB is downgrading its call on Raffles Medical Group (RMG) to “sell” from “neutral” with an unchanged $1.02 target price.